Table 1.
Clinical characteristics of subjects according to the menopausal status.
| Characteristic | Pre-C N = 50 | Pre-BC N = 100 | Post-C N = 17 | Post-BC N = 100 | p |
|---|---|---|---|---|---|
| Age (m ± sd) | 35.4 ± 6 | 41.5 ± 5.2 | 61.6 ± 8.9 | 60.08 ± 5.8 | <0.001 |
| BMI | 23.6 ± 4.4 | 24.3 ± 4.2 | 0.209 | ||
| Grade | 0.261 | ||||
| Grade 1 | – | 10 (10.0%) | – | 7 (7.0%) | |
| Grade 2 | – | 60 (60.0%) | – | 71 (71.0%) | |
| Grade 3 | – | 30 (30.0%) | – | 22 (22.0%) | |
| Stage | 0.657 | ||||
| Stage I | – | 63 (63.0%) | – | 66 (66.0%) | |
| Stage II | – | 37 (37.0%) | – | 34 (34.0%) | |
| Tumor size (mm) | – | 24.9 ± 15.4 | – | 21.3 ± 10.2 | 0.049 |
| ER | 0.182 | ||||
| – | – | 13 (13.0%) | – | 20 (20.0%) | |
| + | – | 87 (87.0%) | – | 80 (80.0%) | |
| PR | 0.008 | ||||
| – | – | 20 (20.0%) | – | 37 (37.0%) | |
| + | – | 80 (80.0%) | – | 63 (63.0%) | |
| HER2 | 0.102 | ||||
| – | – | 80 (80.0%) | – | 70 (70.0%) | |
| + | – | 20 (20.0%) | – | 30 (30.0%) | |
| Ki67 | 0.199 | ||||
| – | – | 39 (39.0%) | – | 48 (48.0%) | |
| + | – | 61 (61.0%) | – | 52 (52.0%) |
p value: Comparison between Pre-BC and Post-BC with t-test and Chi-squared test.